製品の概要

  • 製品名Caffeic acid
  • 製品の詳細
    Specific NF-κB inhibitor
  • 生理活性の詳細Specific NF-κB inhibitor (IC50 = 8.8 μM). Antioxidant, immunomodulatory and anti-inflammatory effects in vitro and in vivo. Additionally inhibits HDAC (IC50 = 0.85 mM). Blood-brain barrier permeable.
  • 精製度> 98%

製品の特性

    Caffeic acid (ab120862) 使用論文

    This product has been referenced in:
    • Tsai SJ  et al. Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice. Eur J Pharmacol 670:441-7 (2011). Read more (PubMed: 21970803) »
    • Mori H & Iwahashi H Antioxidant Activity of Caffeic Acid through a Novel Mechanism under UVA Irradiation. J Clin Biochem Nutr 45:49-55 (2009). Read more (PubMed: 19590707) »
    • Waldecker M  et al. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem 19:587-93 (2008). Read more (PubMed: 18061431) »
    • Fitzpatrick LR  et al. Caffeic acid phenethyl ester, an inhibitor of nuclear factor-kappaB, attenuates bacterial peptidoglycan polysaccharide-induced colitis in rats. J Pharmacol Exp Ther 299:915-20 (2001). Read more (PubMed: 11714876) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120862.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"